Loading...
Back
GSK
GSK
GSK PLC
(GSK)
2026 6-K
Follow
Summary
Share
Summary
Director Shareholding
1 Apr '26
Voting Rights Update
1 Apr '26
Share Buyback Announcement
1 Apr '26
Shareholding Update
1 Apr '26
Share Buyback Announcement
31 Mar '26
Drug Review Acceptance
30 Mar '26
Asthma Drug Approval
30 Mar '26
Share Buyback Announcement
30 Mar '26
Share Buyback Update
27 Mar '26
EMA Review Accepted
27 Mar '26
Share Buyback Announcement
26 Mar '26
Director Shareholding
25 Mar '26
Annual Meeting Notice
25 Mar '26
Share Buyback Alert
25 Mar '26
Share Buyback Completed
24 Mar '26
Director Shareholding
23 Mar '26
Share Admission Notice
23 Mar '26
Orphan Drug Designation
23 Mar '26
Share Buyback Announcement
23 Mar '26
Share Buyback Announcement
20 Mar '26
FDA Approval Granted
19 Mar '26
Share Buyback Update
19 Mar '26
Director Shareholding
18 Mar '26
Share Buyback Announced
18 Mar '26
Director Shareholding
17 Mar '26
Share Buyback Announcement
17 Mar '26
Share Buyback Announcement
16 Mar '26
Vaccine Approval
13 Mar '26
Share Buyback Update
13 Mar '26
Share Acquisition Update
12 Mar '26
Share Buyback Announcement
12 Mar '26
Share Buyback Update
11 Mar '26
Share Buyback Announcement
10 Mar '26
Board Committee Change
9 Mar '26
Global Rights Agreement
9 Mar '26
Share Buyback Update
9 Mar '26
Annual Report Filing
6 Mar '26
Share Buyback Announced
6 Mar '26
Annual Report Published
5 Mar '26
Share Buyback Announcement
5 Mar '26
Director Shareholding
4 Mar '26
Share Buyback Announcement
4 Mar '26
Acquisition Complete
3 Mar '26
Share Buyback Announcement
3 Mar '26
Share Buyback Activity
2 Mar '26
Voting Rights Update
2 Mar '26
Shareholding Update
27 Feb '26
Share Buyback Update
27 Feb '26
Linerixibat Review
26 Feb '26
Regulatory Filing
26 Feb '26
Share Buyback Announcement
26 Feb '26
PDMR Shareholding Update
25 Feb '26
Director Shareholding Update
25 Feb '26
GSK Acquisition Announcement
25 Feb '26
Share Buyback Update
25 Feb '26
Director Shareholding
24 Feb '26
Share Buyback Update
24 Feb '26
Share Buyback Program
23 Feb '26
Director Shareholding
20 Feb '26
Share Buyback Announcement
20 Feb '26
Director Shareholding
19 Feb '26
Share Buyback Announcement
19 Feb '26
Share Buyback Update
18 Feb '26
Director Shareholding Notif...
17 Feb '26
Performance Awards Vested
17 Feb '26
Share Buyback Update
17 Feb '26
EU Approval Granted
17 Feb '26
Share Awards Granted
17 Feb '26
Bonus Share Awards
17 Feb '26
Managerial Awards
17 Feb '26
Director Shareholdings
11 Feb '26
Share Vesting Notification
11 Feb '26
Director Shareholding
11 Feb '26
Share Awards Vesting
11 Feb '26
GSK Vaccine Review
10 Feb '26
Director Shareholding
9 Feb '26
Share Purchase Notification
6 Feb '26
Nucala Approved
6 Feb '26
Director Shareholding
5 Feb '26
Strong 2025 Performance
4 Feb '26
Voting Rights Update
2 Feb '26
Vaccine Approval
26 Jan '26
GSK Acquisition
20 Jan '26
Shareholding Change
20 Jan '26
Director Shareholding
16 Jan '26
Share Acquisition Report
15 Jan '26
Share Acquisition Notification
13 Jan '26
Shingrix Approval
7 Jan '26
Positive Trial Results
7 Jan '26
Approval in Japan
6 Jan '26
Share Acquisition Notification
5 Jan '26
Total Voting Rights
5 Jan '26
Nucala Approved China
5 Jan '26
Drug Price Reduction
23 Dec '25
Director Share Purchases
22 Dec '25
Share Buyback Update
22 Dec '25
Share Buyback Update
19 Dec '25
Share Buyback Announcement
18 Dec '25
FDA Approval Announcement
17 Dec '25
Share Buyback Announcement
17 Dec '25
UK Approval of Exdensur
16 Dec '25
Share Buyback Details
16 Dec '25
Share Buyback Action
15 Dec '25
Positive CHMP Opinion
12 Dec '25
Nucala Approval Opinion
12 Dec '25
Positive CHMP Opinion
12 Dec '25
Share Buyback Update
12 Dec '25
FDA Approval Announcement
11 Dec '25
Share Acquisition Notification
11 Dec '25
Block Listing Application
11 Dec '25
Share Buyback Announcement
11 Dec '25
Share Buyback Update
10 Dec '25
FDA Designation Granted
10 Dec '25
Share Sale Notification
9 Dec '25
Share Buyback Update
9 Dec '25
Share Buyback Announcement
8 Dec '25
Share Buyback Update
5 Dec '25
Share Buyback Report
4 Dec '25
Share Buyback Details
3 Dec '25
Share Buyback Update
2 Dec '25
Director Shareholding
1 Dec '25
Voting Rights Update
1 Dec '25
Share Buyback Update
1 Dec '25
Share Buyback Announcement
28 Nov '25
Share Buyback Announcement
28 Nov '25
Share Buyback Announcement
26 Nov '25
Share Buyback Update
25 Nov '25
Litigation Initiated
21 Nov '25
Share Buyback Announcement
21 Nov '25
Share Buyback Announcement
20 Nov '25
Share Transfer Announcement
19 Nov '25
Share Buyback Activity
19 Nov '25
Director Shareholding
18 Nov '25
Share Buyback Announced
18 Nov '25
Share Buyback Details
17 Nov '25
Share Buyback Update
14 Nov '25
Director Shareholdings
13 Nov '25
Share Buyback Announcement
13 Nov '25
Block Listing Review
12 Nov '25
Share Buyback Update
12 Nov '25
Share Buyback Update
12 Nov '25
Dividend Dates Announced
10 Nov '25
Share Buyback Activity
10 Nov '25
Share Buyback Update
7 Nov '25
Share Buyback Announcement
6 Nov '25
Share Buyback Announcement
5 Nov '25
Share Buyback Announcement
4 Nov '25
Voting Rights Update
3 Nov '25
Share Buyback Announcement
3 Nov '25
Share Buyback Initiated
31 Oct '25
Shareholder Transactions
30 Oct '25
Share Buyback Update
30 Oct '25
Share Buyback Program
29 Oct '25
Strong Q3 Results
29 Oct '25
Share Buyback Report
28 Oct '25
Orphan Drug Designation
28 Oct '25
Share Buyback Update
27 Oct '25
FDA Approval News
24 Oct '25
Share Buyback Completed
24 Oct '25
Share Buyback Update
23 Oct '25
Positive Inhaler Data
22 Oct '25
Share Buyback Update
22 Oct '25
Latozinemab Update
22 Oct '25
Positive CHMP Opinion
21 Oct '25
Share Buyback Announcement
21 Oct '25
Positive Phase III Results
21 Oct '25
Share Buyback Announcement
20 Oct '25
Share Buyback Announcement
17 Oct '25
Share Acquisition Details
16 Oct '25
Share Buyback Notification
16 Oct '25
Director Shareholding
15 Oct '25
Share Buyback Announcement
15 Oct '25
Shingrix Approval
14 Oct '25
Share Buyback Announcement
14 Oct '25
Director Shareholding
14 Oct '25
Share Buyback Announcement
14 Oct '25
Insider Share Acquisitions
10 Oct '25
Share Buyback Event
10 Oct '25
Share Buyback Announcement
9 Oct '25
Share Buyback Update
8 Oct '25
Share Buyback Announcement
7 Oct '25
Share Buyback Update
6 Oct '25
Share Buyback Update
3 Oct '25
Share Buyback Announcement
2 Oct '25
Voting Rights Update
1 Oct '25
Share Buyback Activity
1 Oct '25
Share Buyback Update
30 Sep '25
CEO Appointment
29 Sep '25
Share Purchases Report
22 Sep '25
Share Buyback Update
19 Sep '25
Share Purchase Announcement
18 Sep '25
GSK Investment Plans
17 Sep '25
Share Buyback Announcement
17 Sep '25
Share Buyback Announcement
16 Sep '25
Share Buyback Update
15 Sep '25
Share Buyback Announcement
12 Sep '25
Share Buyback Update
11 Sep '25
Director Shareholding Update
10 Sep '25
Share Buyback Announcement
10 Sep '25
Share Buyback Announcement
9 Sep '25
Share Buyback Announcement
8 Sep '25
Share Buyback Announcement
5 Sep '25
Share Award Notification
4 Sep '25
Share Buyback Announcement
4 Sep '25
Share Buyback Announcement
3 Sep '25
Share Buyback Report
2 Sep '25
Voting Rights Update
2 Sep '25
Share Buyback Update
2 Sep '25
Share Buyback Update
29 Aug '25
Share Buyback
28 Aug '25
Share Buyback Update
27 Aug '25
Share Buyback Announcement
26 Aug '25
Share Buyback Announcement
22 Aug '25
Shareholding Update
21 Aug '25
Share Buyback Report
21 Aug '25
Share Buyback Update
20 Aug '25
Equity Acquisition
19 Aug '25
Share Buyback Update
19 Aug '25
Share Buyback Activity
18 Aug '25
Share Buyback Update
15 Aug '25
Share Buyback Announcement
14 Aug '25
Share Buyback Update
13 Aug '25
Executive Share Acquisition
12 Aug '25
Share Buyback Announcement
12 Aug '25
FDA Review Acceptance
11 Aug '25
Share Buyback Update
11 Aug '25
Patent Settlement
8 Aug '25
Share Buyback Announcement
8 Aug '25
Share Buyback Announcement
7 Aug '25
Share Buyback Announcement
6 Aug '25
Share Buyback Update
5 Aug '25
Share Buyback Announcement
4 Aug '25
Voting Rights Update
1 Aug '25
Share Buyback Process
1 Aug '25
Share Buyback Update
31 Jul '25
Strong 2Q Performance
30 Jul '25
Share Buyback Update
30 Jul '25
Share Buyback Announcement
29 Jul '25
New Collaboration
28 Jul '25
Share Buyback Update
28 Jul '25
Share Buyback Announcement
25 Jul '25
Blenrep Approval
24 Jul '25
Share Buyback Details
24 Jul '25
FDA Review Extended
23 Jul '25
Share Buyback Announcement
23 Jul '25
Share Buyback Update
22 Jul '25
Share Buyback Announcement
21 Jul '25
Share Acquisition Notification
18 Jul '25
FDA Advisory Committee Outcome
18 Jul '25
Share Buyback Announcement
18 Jul '25
Shingrix Approval
17 Jul '25
Share Buyback Process
17 Jul '25
Share Buyback Announcement
16 Jul '25
Share Acquisitions
15 Jul '25
Share Buyback Update
15 Jul '25
Share Acquisitions
14 Jul '25
FDA Review Submission
14 Jul '25
Share Buyback Update
14 Jul '25
Share Buyback Details
11 Jul '25
Share Buyback Announcement
10 Jul '25
Share Buyback Announcement
9 Jul '25
Share Buyback
8 Jul '25
GSK Acquisition Complete
7 Jul '25
Share Buyback Program
7 Jul '25
Share Buyback
7 Jul '25
Share Buyback Update
3 Jul '25
Share Buyback Announcement
2 Jul '25
Voting Rights Update
1 Jul '25
Share Buyback Update
1 Jul '25
Share Buyback Update
30 Jun '25
Share Buyback Activity
27 Jun '25
Share Buyback Update
26 Jun '25
Share Buyback Update
25 Jun '25
Share Transactions
24 Jun '25
Director Appointment
24 Jun '25
Share Buyback Acquisition
24 Jun '25
Share Purchases Revealed
23 Jun '25
Drug Review Accepted
23 Jun '25
Share Buyback Update
23 Jun '25
RSV Vaccine Update
20 Jun '25
Share Buyback Program
20 Jun '25
Share Buyback Update
20 Jun '25
Share Buyback Announcement
18 Jun '25
Share Buyback Update
17 Jun '25
Share Buyback Announcement
16 Jun '25
Share Sale Notification
13 Jun '25
Share Buyback Program
13 Jun '25
RSV Vaccine Update
13 Jun '25
Director Shareholding
12 Jun '25
Share Buyback Update
12 Jun '25
Share Sale Notification
11 Jun '25
Share Buyback Update
11 Jun '25
Share Buyback Program
10 Jun '25
Share Buyback Announcement
9 Jun '25
Share Buyback Announcement
6 Jun '25
Share Buyback Update
5 Jun '25
Share Buyback Announcement
4 Jun '25
Share Buyback Announcement
4 Jun '25
Share Buyback Announcement
3 Jun '25
Share Sale Notification
2 Jun '25
Voting Rights Update
2 Jun '25
FDA Review Acceptance
2 Jun '25
Share Buyback Report
2 Jun '25
Share Buyback Report
30 May '25
Share Buyback Announced
29 May '25
Trial Stopped Early
28 May '25
Share Buyback Announcement
28 May '25
Share Buyback Announcement
27 May '25
Positive CHMP Opinion
23 May '25
FDA Approval News
23 May '25
Share Buyback Announced
23 May '25
Share Buyback Update
22 May '25
Share Buyback Activity
21 May '25
Shareholding Update
20 May '25
Share Buyback Announcement
20 May '25
Blenrep Approval
19 May '25
Share Buyback Announcement
19 May '25
Share Buyback Announcement
16 May '25
Share Buyback Announcement
15 May '25
GSK Acquisition Announcement
14 May '25
Share Buyback Announcement
14 May '25
Share Acquisitions
13 May '25
Belrestotug Development Ended
13 May '25
Share Buyback Update
13 May '25
Block Listing Update
12 May '25
Share Buyback Update
12 May '25
Share Buyback Update
9 May '25
CEO Share Award
8 May '25
Share Vesting Update
8 May '25
Linerixibat Trial Results
8 May '25
Share Buyback Update
8 May '25
AGM Results Report
7 May '25
Share Buyback Announcement
7 May '25
Share Buyback Announcement
6 May '25
Share Buyback Announcement
2 May '25
Director Shareholding
1 May '25
Voting Rights Update
1 May '25
Positive Trial Results
1 May '25
Share Buyback Announcement
1 May '25
Share Buyback Announcement
30 Apr '25
Q1 2025 Results
30 Apr '25
Share Buyback Announcement
29 Apr '25
Share Buyback Update
28 Apr '25
Share Buyback Completed
25 Apr '25
Share Buyback Update
24 Apr '25
Share Buyback Activity
23 Apr '25
Share Buyback Announcement
22 Apr '25
Blenrep Approval
17 Apr '25
Dividend Reinvestment
17 Apr '25
RSV Vaccine Recommendation
17 Apr '25
Vaccine Recommendation
17 Apr '25
Share Buyback Update
17 Apr '25
Share Buyback Update
16 Apr '25
Share Acquisitions
15 Apr '25
Share Buyback Update
15 Apr '25
Director Share Acquisitions
14 Apr '25
Share Buyback Announcement
14 Apr '25
Director Share Acquisitions
11 Apr '25
Share Buyback Announcement
11 Apr '25
Share Buyback Announcement
10 Apr '25
Share Purchase Announcement
9 Apr '25
Share Buyback Announcement
8 Apr '25
Share Buyback Announcement
7 Apr '25
Share Buyback Announcement
4 Apr '25
Share Buyback Announcement
3 Apr '25
Share Buyback Announcement
2 Apr '25
Voting Rights Update
1 Apr '25
Share Repurchase Announcement
1 Apr '25
Share Buyback Announcement
31 Mar '25
Director Shareholding Changes
28 Mar '25
Share Buyback Announcement
28 Mar '25
Share Buyback Announcement
27 Mar '25
Share Buyback Announcement
26 Mar '25
FDA Approval Announcement
25 Mar '25
Share Buyback Announcement
25 Mar '25
AGM Notice Issued
24 Mar '25
Nucala Review Acceptance
24 Mar '25
Share Buyback Details
24 Mar '25
Director Shareholding
21 Mar '25
Share Buyback Update
21 Mar '25
Share Buyback Announcement
20 Mar '25
Share Buyback Program
19 Mar '25
Share Buyback Announcement
18 Mar '25
Share Buyback Announcement
17 Mar '25
Share Transactions
14 Mar '25
Buyback Announcement
14 Mar '25
Filing Notification
13 Mar '25
Share Buyback Announcement
13 Mar '25
Share Buyback Update
12 Mar '25
Share Buyback
11 Mar '25
Share Buyback Announcement
10 Mar '25
Share Buyback Update
7 Mar '25
Share Buyback Update
6 Mar '25
Share Buyback Report
5 Mar '25
Share Buyback Announcement
4 Mar '25
Annual Report Filing
3 Mar '25
Voting Rights Update
3 Mar '25
FDA Review Accepted
3 Mar '25
Clinical Trial Results
3 Mar '25
Share Buybacks Announcement
3 Mar '25
Share Buyback Announcement
28 Feb '25
Share Buyback Announcement
27 Feb '25
Annual Report Released
27 Feb '25
Director Transactions
26 Feb '25
Share Buyback Announcement
26 Feb '25
Share Buyback Plan
25 Feb '25
Acquisition Completed
24 Feb '25
Share Buyback Programme
24 Feb '25
Board Change Announced
21 Feb '25
Share Awards Granted
21 Feb '25
Bonus Awards Granted
21 Feb '25
Shareholding Update
21 Feb '25
Share Vesting Report
21 Feb '25
Share Vesting Notification
21 Feb '25
Executive Share Transactions
21 Feb '25
Nucala Drug Update
20 Feb '25
Vaccine Approval
18 Feb '25
Share Transactions
13 Feb '25
Share Vesting Report
11 Feb '25
Strong 2024 Results
5 Feb '25
Voting Rights Update
3 Feb '25
New Drug Review
28 Jan '25
EMA Review Accepted
28 Jan '25
Shingrix Review Accepted
27 Jan '25
Jemperli Approval Expansion
21 Jan '25
Share Acquisition Report
16 Jan '25
Shareholding Increase
15 Jan '25
Share Acquisitions
14 Jan '25
Share Acquisition Details
13 Jan '25
GSK Acquisition News
13 Jan '25
Shingrix FDA Review
10 Jan '25
FDA Breakthrough Designation
7 Jan '25
Nucala Approved
3 Jan '25
Voting Rights Update
2 Jan '25
Director Share Purchases
23 Dec '24
Block Listing Application
20 Dec '24
Trial Results Announced
20 Dec '24
FDA Designation Granted
16 Dec '24
EMA Designation Granted
16 Dec '24
Positive Approval Opinion
16 Dec '24
Director Shareholding Update
12 Dec '24
Blenrep Success
9 Dec '24
Regulatory Acceptance
9 Dec '24
FDA Submission Accepted
9 Dec '24
Vaccine Collaboration Extended
5 Dec '24
Transaction Notification
2 Dec '24
Voting Rights Update
2 Dec '24
Vaccine Approval
27 Nov '24
FDA Review Accepted
25 Nov '24
RSV Vaccine Approval
22 Nov '24
Share Acquisition Report
19 Nov '24
Linerixibat Success
19 Nov '24
Survival Results Announced
14 Nov '24
Block Listing Review
13 Nov '24
Director Share Transactions
12 Nov '24
Dividend Dates Announced
12 Nov '24
Voting Rights Update
1 Nov '24
Shareholding Update
30 Oct '24
Q3 2024 Results
30 Oct '24
RSV Vaccine Update
24 Oct '24
Director Shareholdings
17 Oct '24
Share Acquisitions
16 Oct '24
FDA Approval News
16 Oct '24
Director Shareholding Update
15 Oct '24
ANCHOR Trials Results
15 Oct '24
Share Acquisitions
11 Oct '24
Share Acquisition
10 Oct '24
Zantac Litigation Settlements
9 Oct '24
Positive Vaccine Data
8 Oct '24
Voting Rights Update
1 Oct '24
Director Share Purchases
24 Sep '24
Positive Vaccine Opinion
24 Sep '24
Zantac Settlements
18 Sep '24
Regulatory Review Accepted
17 Sep '24
Blenrep Therapy Designation
13 Sep '24
Director Shareholding
12 Sep '24
Positive Vaccine Results
12 Sep '24
Zantac Settlement
11 Sep '24
Office Relocation
11 Sep '24
HSV Vaccine Update
11 Sep '24
Asthma Treatment Breakthrough
9 Sep '24
Share Award Notification
6 Sep '24
Nucala Trial Success
6 Sep '24
Total Voting Rights
3 Sep '24
EMA Approval Announcement
29 Aug '24
Nucala Approved
28 Aug '24
SENKU Designation Granted
28 Aug '24
Zantac Litigation Update
28 Aug '24
Director Shareholding
21 Aug '24
Director Shareholding
20 Aug '24
FDA Designation Granted
20 Aug '24
Court Ruling Favor
16 Aug '24
Share Acquisition Report
12 Aug '24
Litigation Verdict
6 Aug '24
Jemperli Approval Expanded
2 Aug '24
Voting Rights Update
1 Aug '24
Strong Q2 Performance
31 Jul '24
Zantac Litigation Update
29 Jul '24
Positive Vaccine Opinion
29 Jul '24
EMA Review Accepted
19 Jul '24
External Links:
SEC
GSK plc reported that Maya Martinez-Davis, President US, acquired 6.679 American Depositary Shares on March 23, 2026, at a price of $51.99 each.
AI Assistant
Close
GSK PLC
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.